Optogenetic Therapy With UGX-201 in Advanced Nonsyndromic Retinitis Pigmentosa: Safety and Efficacy From an Exploratory Clinical Trial
Open Access
- 8 April 2026
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 287, 222-236
Abstract
No abstract availableKeywords
Funding Information
- Soochow University
This publication has 46 references indexed in Scilit:
- Safety of intravitreally delivered AAV2 vector‐mediated multi‐characteristic opsin genetic construct in wild type beagle dogsThe Journal of Gene Medicine, 2024
- Phase 1/2 AAV5-hRKp.RPGR (Botaretigene Sparoparvovec) Gene Therapy: Safety and Efficacy in RPGR-Associated X-Linked Retinitis PigmentosaAmerican Journal of Ophthalmology, 2024
- Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis PigmentosaJAMA Ophthalmology, 2018
- Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trialHuman Genetics, 2016
- Optogenetic approaches to restoring visual function in retinitis pigmentosaCurrent Opinion in Neurobiology, 2011
- Psychophysical assessment of low visual function in patients with retinal degenerative diseases (RDDs) with the Diagnosys full-field stimulus threshold (D-FST)Documenta Ophthalmologica, 2009
- Gene mutations in retinitis pigmentosa and their clinical implicationsClinica Chimica Acta, 2005
- Development of the 25-list-item National Eye Institute Visual Function QuestionnaireArchives of Ophthalmology (1950), 2001
- Preservation of the Inner Retina in Retinitis PigmentosaArchives of Ophthalmology (1950), 1997
- Dependence of cone b-wave implicit time on rod amplitude in retinitis pigmentosaVision Research, 1987